CoVid-19 has dominated conversations worldwide over the last eighteen months, and the effect of both the virus and the responses of governments to the virus could affect every country in the world for generations.
It’s been a nightmare for many people.
So, it makes sense that many people have been excited about taking a CoVid-19 vaccine. After all, the people who keep telling us to “trust the science” (usually without actually being able to tell us what the scientific method is or how it works) have been saying that we all need to take a vaccine so that we can all be safe from the virus.
A new study out of the U.K., though, gives a disturbing report about the long-term usefulness of those vaccines. A writer going by Pa writes,
Antibody levels generated by two doses of the Oxford/AstraZeneca or Pfizer/BioNTech coronavirus vaccine may start to fall six weeks after the second jab, and for some could drop by up to 50 percent in less than three months, research suggests.
University College London’s (UCL) Virus Watch study analysed blood from 552 vaccinated people mostly in their 50s and 60s.
Antibody levels varied widely between patients, but a double dose of Pfizer/BioNTech produced more antibodies against the virus than two Oxford jabs.
For the Pfizer vaccine, antibody levels fell from an average of 7,506 units per millilitre (ml) at 21–41 days, to 3,320 units per ml at 70 or more days.
For the Oxford jab, they fell from 1,201 units per ml at 0–20 days to 190 units per ml at 70 or more days.
The findings are published in the results in a research letter to the Lancet.
But wait a minute. I thought that the point of the vaccines was to get people’s bodies to develop the virus antibodies so that they never catch a serious case of the virus. But this study indicates that the vaccines aren’t having any long-term effectiveness. Not even a year.
Doesn’t that make you question the usefulness of those vaccines in the first place?